Ritipenem

Chemical compound
  • 84845-57-8 checkY
PubChem CID
  • 65633
ChemSpider
  • 59074
UNII
  • D4SL77931L
ChEMBL
  • ChEMBL70088
CompTox Dashboard (EPA)
  • DTXSID60868840 Edit this at Wikidata
Chemical and physical dataFormulaC10H12N2O6SMolar mass288.27 g·mol−13D model (JSmol)
  • Interactive image
  • C[C@@H](O)[C@@H]1[C@H]2SC(=C(N2C1=O)C(=O)O)COC(=O)N
InChI
  • InChI=1S/C10H12N2O6S/c1-3(13)5-7(14)12-6(9(15)16)4(19-8(5)12)2-18-10(11)17/h3,5,8,13H,2H2,1H3,(H2,11,17)(H,15,16)/t3-,5+,8-/m1/s1
  • Key:IKQNRQOUOZJHTR-UWBRJAPDSA-N

Ritipenem is a penem class antimicrobial agent. Ritipenem is manufactured by Tanabe Seiyaku in the ritipenem acoxil prodrug form, which can be taken orally . It is not FDA approved in the United States as of 2008.

References

  • Eiland III EH, Gatlin D (October 2008). "Forecast of antibiotic development in an era of increasing bacterial resistance". Journal of Pharmacy Practice. 21 (5): 313–8. doi:10.1177/0897190008318499. S2CID 71894409.
  • v
  • t
  • e
Antibacterials active on the cell wall and envelope (J01C-J01D)
Beta-lactams
(inhibit synthesis
of peptidoglycan
layer of bacterial
cell wall by binding
to and inhibiting
PBPs, a group of
D-alanyl-D-alanine
transpeptidases)
Penicillins (Penams)
Narrow
spectrum
β-lactamase sensitive
(1st generation)
β-lactamase resistant
(2nd generation)
Extended
spectrum
Aminopenicillins (3rd generation)
Carboxypenicillins (4th generation)
Ureidopenicillins (4th generation)
Other
Carbapenems / Penems
Cephems
Cephalosporins
Cephamycins
Carbacephems
1st generation
2nd generation
3rd generation
4th generation
5th generation
Siderophore
Veterinary
Monobactams
β-lactamase inhibitors
Combinations
Polypeptides
Glycopeptides
Lipoglycopeptides
Lipopeptides
Polymyxins
Other
  • Inhibits PG elongation and crosslinking: Ramoplanin§
Intracellular
Other


Stub icon

This systemic antibiotic-related article is a stub. You can help Wikipedia by expanding it.

  • v
  • t
  • e